多功能持续湿化装置在气管造口患者中的设计与应用
该研究由杭州市第一人民医院重症医学科设计了一种由罩体、连接管和雾化器组成的多功能持续湿化装置(获国家实用新型专利,专利号ZL 2021 2 0079525.4),并纳入2023年8月至2024年6月该院ICU 48例经气管造口氧疗患者,按1:1随机分为试验组(n=24)和对照组(n=24),从撤机过渡至经气管造口持续吸氧开始,试验组用该装置湿化、对照组用传统湿化器,每日湿化方案一致并由经同质化培训的护理人员实施。结果显示试验组并发症发生率低于对照组:结痂4%(1/24)vs 54%(13/24)、气道黏膜损伤8%(2/24)vs 42%(10/24)、肺部感染4%(1/24)vs 54%(13/24);护士满意度试验组100%(24/24)vs 对照组17%(4/24),差异均有统计学意义(均P<0.05);第1、7、14天痰液黏稠度分级试验组均优于对照组(均P<0.05)。作者认为该装置能有效维持气道湿化、保证呼吸道通畅、提高气道清除效果、减少吸痰频率、预防气道并发症并提升护理效率,具有良好的临床推广潜力。
要点
- 试验组气管造口氧疗期间结痂4%(1/24)vs 对照组54%(13/24),差异有统计学意义(P<0.05)。
- 试验组气道黏膜损伤8%(2/24)vs 对照组42%(10/24),差异有统计学意义(P<0.05)。
- 试验组肺部感染4%(1/24)vs 对照组54%(13/24),差异有统计学意义(P<0.05)。
- 护士满意度试验组100%(24/24)vs 对照组17%(4/24),差异有统计学意义(P<0.05)。
- 第1、7、14天痰液黏稠度分级试验组均优于对照组(均P<0.05)。
适用人群与场景
- 杭州市第一人民医院ICU 2023年8月至2024年6月经气管造口行氧疗的患者,共48例。
- 从撤机过渡至经气管造口持续吸氧开始时启动湿化干预。
处置流程与药物剂量
- 试验组(n=24)从撤机过渡至经气管造口持续吸氧开始,使用多功能持续湿化装置(由罩体、连接管和雾化器组成)进行湿化。
- 对照组(n=24)使用传统湿化器进行湿化。
- 两组每日湿化方案一致,由经同质化培训的护理人员实施。
研究设计与关键结果
- 研究类型为随机对照试验,样本量48例,单中心(杭州市第一人民医院ICU),按随机数字表1:1分为试验组(n=24)和对照组(n=24)。
- 两组性别、年龄、疾病类型及湿化前痰液黏稠度分级差异无统计学意义。
- 试验组结痂4%(1/24)vs 对照组54%(13/24),差异有统计学意义(P<0.05)。
- 试验组气道黏膜损伤8%(2/24)vs 对照组42%(10/24),差异有统计学意义(P<0.05)。
- 试验组肺部感染4%(1/24)vs 对照组54%(13/24),差异有统计学意义(P<0.05)。
- 护士满意度试验组100%(24/24)vs 对照组17%(4/24),差异有统计学意义(P<0.05)。
- 第1、7、14天痰液黏稠度分级试验组均优于对照组(均P<0.05)。
证据类型、等级与局限
- 证据类型:随机对照试验。
- 该装置已获国家实用新型专利(专利号:ZL 2021 2 0079525.4)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该装置在气管造口患者中应用可有效维持气道湿化、保证呼吸道通畅、提高气道清除效果、减少吸痰频率、预防气道并发症并提升护理效率,具有良好的临床推广潜力。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Tracheostomy is an important therapeutic measure to relieve airway obstruction and ensure effective ventilation in patients. However, the procedure bypasses the natural upper airway, compromising its normal defensive functions, which can lead to drying of secretions, crust formation, potential tube occlusion, and ultimately pulmonary infection. Adequate airway humidification can help dilute sputum, facilitate sputum drainage, and ultimately reduce the incidence of airway-related complications. Although several airway humidification methods have been reported, their outcomes remain unsatisfactory. To address this, the intensive care unit staff of Hangzhou First People's Hospital, designed a multifunctional continuous humidification device consisting of a cover, connecting tube, and nebulizer for airway humidification, which has been granted a national utility model patent of China (patent number: ZL 2021 2 0079525.4). A total of 48 patients requiring oxygen therapy via a tracheostomy at the intensive care unit of Hangzhou First People's Hospital between August 2023 and June 2024 were selected as the study subjects. Using a random number table, they were assigned in a 1 : 1 ratio to an experimental group (n=24) and a control group (n=24). From the initiation of the transition from mechanical ventilation weaning to continuous oxygen inhalation via the tracheostomy, the experimental group received humidification using the multifunctional continuous humidification device, while the control group received humidification using a traditional humidifier. The daily humidification protocol was consistent for both groups and was implemented by nursing staff who had undergone homogenized training. General patient data, the incidence of complications during humidified oxygen therapy via tracheostomy, nursing staff satisfaction, and sputum viscosity grading on day 1, 7, and 14 of airway humidification were compared between the two groups. The results showed no statistically significant differences in gender, age, disease types, or pre-humidification sputum viscosity grades between the two groups. The incidence of complications in the experimental group was lower than that in the control group during the treatment [crust formation: 4% (1/24) vs. 54% (13/24); airway mucosal injury: 8% (2/24) vs. 42% (10/24); pulmonary infection: 4% (1/24) vs. 54% (13/24)]. Nursing staff satisfaction was also found to be significantly higher in the experimental group [100% (24/24) vs. 17% (4/24)]. All these differences were statistically significant (all P<0.05). The sputum viscosity grades on day 1, 7, and 14 were also significantly more favorable in the experimental group than in the control group (all P<0.05). These findings indicate that the application of this device in tracheostomy patients effectively maintained airway humidification, ensured respiratory tract patency, improved airway clearance efficacy, reduced the frequency of sputum suction, and prevented airway complications, and enhances nursing efficiency, demonstrating good potential for clinical promotion.
参考来源
- Peng Q, Zhu M, Chen H, et al. [Design and application of a multifunctional continuous humidification device in tracheostomy patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 41958138. doi:10.3760/cma.j.cn121430-20240805-00665
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。